Navigation Links
New personalized treatment options for cancer
Date:12/19/2011

pre-clinical trials in Australia."

Dr Neilsen lost his 18-year-old brother to Ewing's Sarcoma a malignant bone tumour which occurs most frequently in male teenagers and has a mortality rate of 40%, but increases to 90% for metastatic or recurrent disease.

Adelaide man John Marshall was a lot older 41 years of age when he was diagnosed with Ewing's Sarcoma in July 2010, undergoing surgery to remove the tumour, along with 12 months of chemotherapy.

"The diagnosis floored me. I was a fit, happy, healthy guy who had never smoked, ate a healthy diet and worked out regularly. How could this happen to me?"

While Mr Marshall has been given the all clear following his treatment, he is keen to support sarcoma research being undertaken at the Centre for Cancer Personalised Medicine and the Royal Adelaide Hospital. He is planning a sponsored cycle ride through the French Alps in September 2102.


'/>"/>
Contact: Professor David Callen
david.callen@adelaide.edu.au
61-882-223-145
University of Adelaide
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New book by University of Louisville professor enables reader to develop personalized anti-depression plan
2. Northwestern to explore personalized medicine for scleroderma
3. Tumor-targeting compound points the way to new personalized cancer treatments
4. New and varied imaging techniques facilitate personalized medicine
5. Matching targeted therapies to tumors specific gene mutations key to personalized cancer treatment
6. Breast milk may provide a personalized screen of breast cancer risk
7. WSU researcher creates patented personalized therapy that causes cancer cells to kill themselves
8. IU Personalized Medicine Institute to develop targeted and individualized treatments
9. Tufts University calls for moderate approach to teaching personalized genomic testing
10. Personalized molecular therapy shows promising results for people with advanced lung cancer
11. Personalized vaccine for lymphoma patients extends disease-free survival by nearly 2 years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 The second federal bellwether trial ... Johnson subsidiary Ethicon concluded with the jury in the ... awarding her $3.27 million in damages, according to a ... “jurors found Ethicon liable for selling faulty devices and ... were at risk from side effects that include pain, ...
(Date:9/16/2014)... 16, 2014 Advanced Fertility Center of ... by Houstonia Magazine as one of the Top Doctors ... Magazine - a metropolitan magazine serving the Houston area. ... recognize them for their outstanding services. This accomplishment will ... of Houstonia Magazine — a special publication listing all ...
(Date:9/16/2014)... Duke’s Chowder House Lake Union is ... and Gratafy for a fun evening of tech networking. ... cemented. With the growth of companies in these sectors, there’s also ... work in tech and at startups to connect with each other. ... to host events for their peers to meet and mingle in ...
(Date:9/16/2014)... radiation therapy as part of breast conservation is ... hormone-receptor positive (HR+) invasive breast cancer. A new ... however, shows that combination may not be necessary ... , The results, which Fox Chase researchers presented ... Annual Meeting on Sunday, September 14, suggest that ...
(Date:9/16/2014)... This year’s theme is centered around entrepreneurism ... Mills, Pennsylvania, September 15, 2014- Holganix, an elite member ... growing companies in the country, produces an organic Bionutritional ... health-care by naturally decreasing disease and insect damage though ... that it will hold its third annual Bionutritional Summit ...
Breaking Medicine News(10 mins):Health News:Ethicon to Appeal Bellwether Trial Verdict of $3.27 Million, Rottenstein Law Group LLP Notes 2Health News:Dr. Michael Allon Receives Esteemed Recognition 2Health News:Seattle Seafood Restaurant Duke’s Chowder House Partners with Rebls & Gratafy for Tech Networking Happy Hour Event. 2Health News:Seattle Seafood Restaurant Duke’s Chowder House Partners with Rebls & Gratafy for Tech Networking Happy Hour Event. 3Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 2Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 3Health News:Holganix Holds 3rd Annual Bionutritional Summit in Louisville, Kentucky 2
... Calif., May 27 The Ensign,Group, Inc. (Nasdaq: ... Ensign(TM) group of,skilled nursing, rehabilitative care services and ... in the FBR Capital,Markets 12th Annual Spring Investor ... in New York City. Christopher Christensen, CEO, together ...
... provide the infrastructure for MRF,s collaborative ... ... 27 Collaborative Drug,Discovery, Inc. (CDD) announced today that its ... new drug,candidates, has been selected by the Myelin Repair Foundation ...
... infection following operations for which a "prophylactic" antibiotic is ... than it was just a decade ago, according to ... report their findings in the June 15 issue of ... that have been associated with severe infections, such as ...
... dad is more involved in baby,care than ever before. Whether ... basics, or a new dad to whom the dear wife ... to pack in the "diaper,dude":, The Moms on Call ... pediatric nurse moms, is a guidebook for new dads that ...
... study says , , TUESDAY, May 27 (HealthDay News) -- A ... in nonsmokers, researchers report. , The findings -- that certain ... lung cancer, regardless of whether he or she ever smoked ... said study author Dr. Ping Yang, of the Mayo Clinic. ...
... 27 Somanetics Corporation,(Nasdaq: SMTS ) announced today ... and Drug Administration (FDA) to expand the labeling for ... 510(k) will serve to support our ongoing efforts,in the ... said,Bruce Barrett, Somanetics, president and CEO. "First, the 510(k) ...
Cached Medicine News:Health News:The Ensign Group to Present at the FBR Capital Markets 12th Annual Spring Investor Conference on May 29th 2Health News:The Ensign Group to Present at the FBR Capital Markets 12th Annual Spring Investor Conference on May 29th 3Health News:Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership 2Health News:Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership 3Health News:Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership 4Health News:The balance shifts 2Health News:Father's Day is Almost Here: Two Pediatric Nurses, Moms, Offer Practical Guidebook & DVD for New Dads 2Health News:Common Genetic Variant Tied to Lung Cancer Risk 2Health News:Common Genetic Variant Tied to Lung Cancer Risk 3Health News:Somanetics Receives 510(k) Clearance From the FDA to Expand INVOS System Labeling 2
(Date:9/16/2014)... , Sept. 16, 2014 The Pulmonary Fibrosis ... data from more than 1,100 patients and families suffering ... Drug Administration (FDA) for the Patient-Focused Drug Development Meeting ... a new FDA initiative to seek patient input in ... therapeutic treatments. "We applaud the FDA for ...
(Date:9/16/2014)... , Sept. 16, 2014 Astellas announced ... of Business Communications & Advocacy, Urology in the ... Communications & Advocacy Margaret Long. In this role, Noland ... urology to patient and advocacy organizations, as well ... key strategic initiatives. Noland,s appointment is the latest ...
(Date:9/16/2014)... 2014  Aratana Therapeutics, Inc. (NASDAQ: ... licensing, developing and commercializing innovative biopharmaceutical products for ... an underwritten registered public offering of shares of ... being offered by Aratana Therapeutics. ... book-running managers for the offering.  ...
Breaking Medicine Technology:PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 2PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 3PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 4Christy Noland to Lead Urology Advocacy and Communications for Astellas 2Aratana Therapeutics, Inc. Announces Proposed Public Offering 2
... Oct. 11 Merial, the Animal Health division ... ), announced today that Merial Animal Health Co. (China) held ... located in the Nanchang Hi-tech Development Zone, China. Merial ... the Group,s first production facility in China has been in ...
... , EXTON, Pa., Oct. 9 Kensey Nash Corporation (Nasdaq: ... earnings results for its first quarter ended September 30, 2009 ... , Joe Kaufmann, President and CEO, will be ... 22, 2009 at 9:00 A.M. Eastern Time. , ...
Cached Medicine Technology:Merial invests US $70 million in Nanchang, China 2Merial invests US $70 million in Nanchang, China 3Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference 2
... Digisonics is a web-based application to securely ... cardiovascular modalities. Users can login from ... password to review stored patient studies. ... patient information, images, and reports Quickly locates ...
... stands for Stainless Steel Kleener. SSK-80 is ... and stain remover for ultra-sonic cleaners. , ... of your instruments by removing and inhibiting ... pivot points, box joints and moving instrument ...
... Foam is the ready-to-use, pre-cleaning enzymatic foam ... ,Hemaway Enzymatic Foam sprays on ... It's perfect for use in the O.R. ... Getting a head start with Hemaway Enzymatic ...
... Cytospin has been synonymous with ... More than 15,000 laboratories worldwide ... It provides economical thin-layer preparations ... hypocellular fluids such as spinal ...
Medicine Products: